Certara (NASDAQ:CERT) Shares Gap Up to $13.42

Certara, Inc. (NASDAQ:CERTGet Rating) gapped up before the market opened on Wednesday . The stock had previously closed at $13.42, but opened at $13.89. Certara shares last traded at $13.55, with a volume of 5,965 shares.

Wall Street Analysts Forecast Growth

CERT has been the topic of several analyst reports. Piper Sandler reduced their price target on Certara from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, August 10th. Credit Suisse Group began coverage on shares of Certara in a report on Wednesday, August 24th. They issued an “outperform” rating and a $22.00 price objective on the stock. Barclays reduced their price objective on shares of Certara from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Wednesday, August 17th. Morgan Stanley reduced their price objective on shares of Certara from $24.00 to $20.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 24th. Finally, SVB Leerink reduced their price objective on shares of Certara from $29.00 to $26.00 and set an “outperform” rating on the stock in a report on Wednesday, August 10th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $24.00.

Certara Stock Performance

The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of -217.67, a P/E/G ratio of 0.84 and a beta of 1.27. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.51 and a current ratio of 3.51. The firm has a 50-day simple moving average of $18.40 and a two-hundred day simple moving average of $19.57.

Certara (NASDAQ:CERTGet Rating) last released its earnings results on Tuesday, August 9th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.02). The firm had revenue of $82.00 million during the quarter, compared to analyst estimates of $85.46 million. Certara had a negative net margin of 3.14% and a positive return on equity of 4.26%. The business’s revenue was up 17.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.03 earnings per share. On average, sell-side analysts anticipate that Certara, Inc. will post 0.28 EPS for the current fiscal year.

Insider Buying and Selling at Certara

In other Certara news, insider Patrick F. Smith sold 10,000 shares of Certara stock in a transaction dated Tuesday, August 16th. The stock was sold at an average price of $17.71, for a total value of $177,100.00. Following the completion of the transaction, the insider now directly owns 78,490 shares of the company’s stock, valued at approximately $1,390,057.90. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, insider Patrick F. Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 16th. The stock was sold at an average price of $17.71, for a total transaction of $177,100.00. Following the completion of the transaction, the insider now directly owns 78,490 shares of the company’s stock, valued at $1,390,057.90. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Michael Andrew Schemick acquired 25,000 shares of the stock in a transaction dated Wednesday, August 17th. The shares were bought at an average cost of $16.64 per share, with a total value of $416,000.00. Following the completion of the transaction, the chief financial officer now owns 517,870 shares of the company’s stock, valued at approximately $8,617,356.80. The disclosure for this purchase can be found here. Insiders sold a total of 6,196,893 shares of company stock valued at $107,705,300 in the last three months. 4.02% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Certara

A number of institutional investors and hedge funds have recently made changes to their positions in CERT. Raymond James & Associates grew its position in shares of Certara by 17.4% during the fourth quarter. Raymond James & Associates now owns 20,219 shares of the company’s stock worth $575,000 after buying an additional 3,003 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Certara by 265.1% during the fourth quarter. Principal Financial Group Inc. now owns 27,861 shares of the company’s stock worth $792,000 after purchasing an additional 20,230 shares during the last quarter. Teacher Retirement System of Texas lifted its stake in Certara by 21.9% during the fourth quarter. Teacher Retirement System of Texas now owns 16,773 shares of the company’s stock worth $477,000 after purchasing an additional 3,019 shares during the last quarter. Citigroup Inc. lifted its stake in Certara by 78.5% during the fourth quarter. Citigroup Inc. now owns 55,166 shares of the company’s stock worth $1,568,000 after purchasing an additional 24,254 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Certara by 33.6% during the fourth quarter. Rhumbline Advisers now owns 93,111 shares of the company’s stock worth $2,646,000 after purchasing an additional 23,418 shares during the last quarter. 77.42% of the stock is owned by institutional investors and hedge funds.

Certara Company Profile

(Get Rating)

Certara, Inc provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.

Featured Stories

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.